Evidence map›Paper›PMID 23994286›Full record

ArticleCancer epidemiology2013

Antihistamine use and immunoglobulin E levels in glioma risk and prognosis.

E Susan Amirian, Deborah Marquez-Do, Melissa L Bondy, Michael E Scheurer

Abstract readComparative Study
In one paragraph

Article in Cancer epidemiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. AllergoOncology in Review: Harnessing Allergy in the Field of Oncology to Improve Patient Outcomes.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2026
    Review
  4. Association of immunoglobulin E levels with glioma risk and survival.Journal of the National Cancer Institute · 2025
    Article
  5. Association of immunoglobulin E levels with glioma risk and survival.medRxiv : the preprint server for health sciences · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Allergies and the Subsequent Risk of Cancer among Elderly Adults in the United States.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2019
    Article
  11. Article
  12. Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2016
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

E Susan AmirianDan L. Duncan Cancer Center, Baylor College of Medicine, One Baylor Plaza MS:BCM305, Houston, TX 77030, USA; Department of Pediatrics, Baylor College of Medicine, One Baylor Plaza MS:BCM305, Houston, TX 77030, USA. Electronic address: amirian@bcm.edu.
Deborah Marquez-Do
Melissa L Bondy
Michael E Scheurer

Funding

MOLECULAR EPIDEMIOLOGY OF GLIOMASR01CA070917 · NCI · UNIVERSITY OF TEXAS MD ANDERSON CAN CTR · PI BONDY, MELISSA L · 1996 to 2004
$3.0M
Infection and Inflammation in Adult GliomasK07CA131505 · NCI · BAYLOR COLLEGE OF MEDICINE · PI SCHEURER, MICHAEL E. · 2008 to 2012
$784k
NCI NIH HHS K07 CA131505NCI NIH HHS K07CA131505NCI NIH HHS R01 CA070917NCI NIH HHS R01CA070917
6 · The paper itself

Abstract

objectiveAn inverse association between personal history of allergies/asthma and glioma risk has been fairly consistently reported in the epidemiologic literature. However, the role of regular antihistamine use remains controversial due to a small number of studies reporting contradictory findings. We evaluated the association between regular use of oral antihistamines and glioma risk, adjusting for a number of relevant factors (e.g., immunoglobulin E levels and history of chickenpox).

methodsWe used a subset of the Harris County Case-Control Study, which included 362 pathologically confirmed glioma cases and 462 cancer-free controls, to evaluate this association using unconditional multivariable logistic regression. These models were run among the overall study population and stratified by allergy status. Cox regression was utilized to examine whether antihistamine use was associated with mortality among all cases and separately among high-grade cases.

resultsAntihistamine use was strongly associated with glioma risk among those with a positive allergy/asthma history (OR: 4.19, 95% CI: 2.06-8.51), but not among those with a negative history (OR: 1.59, 95% CI: 0.95-2.67). There were no significant associations between antihistamine use and survival among cases.

conclusionThe current study implies that regular antihistamine use may increase glioma risk. However, several larger studies are necessary before definitive conclusions can be drawn.

Indexed as

AdolescentAdultBrain NeoplasmsCase-Control StudiesEnzyme-Linked Immunosorbent AssayFemaleFollow-Up StudiesGliomaHistamine AntagonistsHumansImmunoglobulin EMaleMiddle AgedNeoplasm GradingPrognosisRisk FactorsHistamine AntagonistsImmunoglobulin EBrain neoplasmsCase-control studiesEpidemiologyHypersensitivityImmunoglobulin ERisk factorsSurvival

Identifiers

PMID23994286
PMCPMC3851921

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.